Canadian Markets close in 3 hrs 21 mins

Eli Lilly and Company (LLY)


NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
84.79+0.04 (+0.05%)
As of 12:39PM EDT. Market open.
People also watch
BMYMRKABTGSKJNJ
Full screen
Previous Close84.75
Open84.62
Bid84.80 x 400
Ask84.81 x 200
Day's Range84.31 - 84.96
52 Week Range64.18 - 86.72
Volume1,500,811
Avg. Volume3,562,485
Market Cap89.19B
Beta0.17
PE Ratio (TTM)41.00
EPS (TTM)2.07
Earnings DateJul 25, 2017
Dividend & Yield2.08 (2.47%)
Ex-Dividend Date2017-08-11
1y Target Est90.24
Trade prices are not sourced from all markets
  • TheStreet.com23 hours ago

    5 New Breast Cancer Treatments That Are Helping to Save Lives

    In the U.S., one in eight women will be diagnosed with breast cancer in their lifetime; for men, the risk is one in 1,000.

  • Reutersyesterday

    FDA tentatively approves Merck's copycat of Sanofi's Lantus

    Merck and Co Inc said on Thursday the U.S. Food and Drug Administration (FDA) tentatively approved its biosimilar version of French drugmaker Sanofi SA's blockbuster diabetes treatment, Lantus. Merck's copycat, if launched, would challenge Lantus as a cheaper alternative that could chip away at the drug's sales, which reached 5.71 billion euros ($6.6 billion) last year and represented over a sixth of Sanofi's total sales.

  • Is a Beat in the Cards for Eli Lilly (LLY) in Q2 Earnings?
    Zacks2 days ago

    Is a Beat in the Cards for Eli Lilly (LLY) in Q2 Earnings?

    Eli Lilly and Company's (LLY) new drugs like Trulicity, Cyramza, Taltz and Jardiance have been performing well. Let's see if these along with its older products lead the company to an earnings beat.